Von Recklinghausen's disease associated with malignant peripheral nerve sheath tumor presenting with constipation and urinary retention: A case report and review of the literature

Anticancer Research

Volumn 28, Issue 5 B, 2008, Pages 3107-3113

  Karatzoglou, Parthena ^a   Karagiannidis, Alexandros ^a   Kountouras, Jannis ^a,b   Christofiridis, Christos V ^a   Karavalaki, Maria ^a   Zavos, Christos ^a   Gavalas, Emmanuel ^a   Patsiaoura, Kalliopi ^a   Vougiouklis, Nikolaus ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

Constipation; Malignant peripheral nerve sheath tumor; Neurofibromatosis 1; Sarcomas; Von Recklinghausen's disease

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; BILE DUCT OBSTRUCTION; CASE REPORT; CLINICAL FEATURE; COLOSTOMY; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE ISCHEMIA; INTUSSUSCEPTION; LABORATORY TEST; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; NEUROFIBROMATOSIS; PERIPHERAL NERVE TUMOR; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TUMOR BIOPSY; URINE RETENTION;

ADULT; CONSTIPATION; FATAL OUTCOME; HUMANS; MALE; NERVE SHEATH NEOPLASMS; NEUROFIBROMATOSIS 1; URINARY RETENTION;

EID: 55749095890     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Brooks JJ: Disorders of soft tissue. In: Diagnostic Surgical Pathology 3rd edition. Sternberg SS, Antonioli DA (eds.). Philadelphia Lippincott Williams & Wilkins, pp. 131-221, 1999.
2. Stevenson DA, Viskochil DH, Schorry EK, Crawford AH, D'Astous J, Murray KA, Friedman JM, Armstrong L and Carey JC: The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1. Genet Med 9: 409-412, 2007.
3. Mirowski GW and Mark LA: Oral disease and oral-cutaneous manifestations of gastrointestinal and liver disease. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Feldman M, Friedman LS, Brandt LJ (eds.). Philadelphia Saunders, pp. 443-463, 2006.
4. Levy AD, Patel N, Dow N, Abbott RM, Miettinen M and Sobin LH: From the archives of the AFIP: abdominal neoplasms in patients with neurofibromatosis type 1: radiologic-pathologic correlation. Radiographics 25: 455-480, 2005.
5. Magro G, Piana M, Venti C, Lacagnina A and Ruggieri M: Solitary neurofibroma of the mesentery: report of a case and review of the literature. Pathol Res Pract 196: 713-718, 2000.
6. Kim HR and Kim YJ: Neurofibromatosis of the colon and rectum combined with other manifestations of von Recklinghausen's disease: report of a case. Dis Colon Rectum 41: 1187-1192, 1998.
7. Watanuki F, Ohwada S, Hosomura Y, Okamura S, Kawashima Y, Tanahashi Y, Nakamura S, Iino Y, Johshita T and Morishita Y: Small ileal neurofibroma causing intussusception in a non-neurofibromatosis patient. J Gastroenterol 30: 113-116, 1995.
8. Maneschg C, Rogatsch H, Bartsch G and Stenzl A: Treatment of giant ancient pelvic schwannoma. Tech Urol 7: 296-298, 2001.
9. Oderich GS, Sullivan TM, Bower TC, Gloviczki P, Miller DV, Babovic-Vuksanovic D, Macedo TA and Stanson A: Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results. J Vasc Surg 46: 475-484, 2007.
10. Hartley N, Rajesh A, Verma R, Sinha R and Sandrasegaran K: Abdominal manifestations of neurofibromatosis. J Comput Assist Tomogr 32: 4-8, 2008.
11. Savar A and Cestari DM: Neurofibromatosis type I: genetics and clinical manifestations. Semin Ophthalmol 23: 45-51, 2008.
12. Von Recklinghausen FD: Über die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen. Hirschwald, Berlin, 1882.
13. Crawford AH and Herrera-Soto J: Scoliosis associated with neurofibromatosis. Orthop Clin North Am 38: 553-562, 2007.
14. Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R and Weiss R: The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62: 599-608, 1990.
15. Marsh D and Zori R: Genetic insights into familial cancers-update and recent discoveries. Cancer Lett 181: 125-164, 2002.
16. Riccardi VM: Neurofibromatosis: Phenotype, Natural History and Pathogenesis. 2nd edition. Baltimore MD, John Hopkins University Press, 1992.
17. Enzinger FM and Weiss SW: Malignant tumors of the peripheral nerves. In: Soft Tissue Tumors, 3rd edition. Enzinger FM, Weiss SW (eds.). St Louis Mosby-Year Book, pp. 889-928, 1995.
18. King AA, Debaun MR, Riccardi VM and Gutmann DH: Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 93: 388-392, 2000.
19. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM and Ilstrup DM: Malignant peripheral nerve sheath tumors: a clinicopathologic study of 120 cases. Cancer 57: 2006-2021, 1986.
20. Kourea HP, Bilsky MH, Leung DH, Lewis JJ and Woodruff JM: Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors: a clinicopathologic study of 25 patients and 26 tumors. Cancer 82: 2191-2203, 1998.
21. Murphey MD, Smith WS, Smith SE, Kransdorf MJ and Temple HT: Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic correlation. Radiographics 19: 1253-1280, 1999.
22. Mautner VF, Friedrich RE, von Deimling A, Hagel C, Korf B, Knöfel MT, Wenzel R and Fünsterer C: MPNSTs in NF-1: MRI supports the diagnosis of malignant plexiform neurofibroma. Neuroradiology 45: 618-625, 2003.
23. Mautner VF, Brenner W, Fünsterer C, Hagel C, Gawad K and Friedrich RE: Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF-1. Anticancer Res 27: 1819-1822, 2007.
24. Chander S, Westphal SM, Zak IT, Bloom DA, Zingas AP, Joyrich RN, Littrup PJ, Taub JW and Getzen TM: Retroperitoneal MPNST: evaluation with serial FDG-PET. Clin Nucl Med 29: 415-418, 2004.
25. Fenton LZ, Foreman N and Wyatt-Ashmead J: Diffuse, retroperitoneal mesenteric and intrahepatic periportal plexiform neurofibroma in a 5-year-old boy. Pediatr Radiol 31: 637-639, 2001.
26. Levine E, Huntrakoon M and Wetzel LH: Malignant nerve-sheath neoplasms in neurofibromatosis: distinction from benign tumors by using imaging techniques. AJR 149: 1059-1064, 1987.
27. Bhargava R, Parham DM, Lasater OE, Chari RS, Chen G and Fletcher BD: MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol 27: 124-129, 1997.
28. Hammond JA and Driedger AA: Detection of malignant change in neurofibromatosis (von Recklinghausen's disease) by gallium-67 scanning. Can Med Assoc J 119: 352-353, 1978.
29. Matsunou H, Shimoda T, Kakimoto S, Yamashita H, Ishikawa E and Mukai M: Histopathologic and immunohistochemical study of MPNSTs (malignant schwannoma). Cancer 56: 2269-2279, 1985.
30. Wick MR, Swanson PE, Scheithauer BW and Manivel JC: MPNST: an immunohistochemical study of 62 cases. Am J Clin Pathol 87: 425-433, 1987.
31. Menon AG, Anderson KM, Riccardi VM, Chung RY, Whaley JM, Yandell DW, Farmer GE, Freiman RN, Lee JK and Li FP: Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen's neurofibromatosis. Proc Natl Acad Sci USA 87: 5435-5439, 1990.
32. Reynolds JE, Fletcher JA, Lytle CH, Nie L, Morton CC and Diehl SR: Molecular characterization of a 17q 11.2 translocation in a malignant schwannoma cell line. Hum Genet 90: 450-456, 1992.
33. INK4a inactivation in sporadic and neurofibromatosis type 1-related MPNSTs. Clin Cancer Res 9: 4132-4138, 2003.
34. Frahm S, Mautner VF, Brems H, Legius E, Debiec-Rychter M, Friedrich RE, Knöfel WT, Peiper M and Kluwe L: Genetic and phenotypic characterization of tumor cells derived from MPNSTs of NF-1 patients. Neurobiol Dis 16: 85-91, 2004.
35. Zhou H, Coffin CM, Perkins SL, Tripp SR, Liew M and Viskochil DH: MPNST. A comparison of grade, immunophenotype and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions. Am J Surg Pathol 27: 1337-1345, 2003.
36. Watanabe T, Oda Y, Tamiya S, Masuda K and Tsuneyoshi M: MPNST arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components. J Clin Pathol 54: 631-636, 2001.
37. DeClue JE, Heffelfinger S, Benvenuto G, Ling B, Li S, Rui W, Vass WC, Viskochil D and Ratner N: EGF receptor expression in NF type 1-related tumors and NF-1 animal models. J Clin Invest 105: 1233-1241, 2000.
38. Stark AM, Buhl R, Hugo HH and Mehdorn HM: MPNSTs-report of 8 cases and review of the literature. Acta Neurochir 143: 357-364, 2001.
39. Korf BR: Malignancy in NF type 1. Oncologist 5: 477-485, 2001.
40. Minovi A, Basten O, Hunter B, Draf W and Bockmühl U: Malignant peripheral nerve sheath tumors of the head and neck: management of 10 cases and literature review. Head Neck 29: 439-445, 2007.
41. Kinebuchi Y, Noguchi W, Igawa Y and Nishizawa O: Recurrent retroperitoneal malignant peripheral nerve sheath tumor associated with neurofibromatosis type I responding to carboplatin and etoposide combined chemotherapy. Int J Clin Oncol 10: 353-356, 2005.
42. Cashen DV, Parisien RC, Raskin K, Hornicek FJ, Gebhardt MC and Mankin HJ: Survival data for patients with malignant schwannoma. Clin Orthop Relat Res 426: 69-73, 2004.
43. Hagel C, Zils U, Peiper M, Kluwe L, Gotthard S, Friedrich RE, Zurakowski D, von Deimling A and Mautner VF: Histopathology and clinical outcome of NF-1-associated vs. sporadic malignant peripheral nerve sheath tumors. J Neurooncol 82: 187-192, 2007.
44. Wanebo JE, Malik JM, VandenBerg SR, Wanebo HJ, Driesen N and Persing JA: MPNSTs: A clinicopathologic study of 28 cases. Cancer 71: 1247-1253, 1993.